Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VECTUS BIOSYSTEMS LIMITED Earnings Release 2023

Aug 29, 2023

65993_rns_2023-08-29_4956df53-686b-4d50-b506-a79d48ebb7ec.pdf

Earnings Release

Open in viewer

Opens in your device viewer

VBS App 4E 30 Jun 2023

Page 1

Rule 4.3A

Appendix 4E

Preliminary final report for the financial year ended 30 June 2023

Name of entity

VECTUS BIOSYSTEMS LIMITED ABN: 54 117 526 137

Reporting period: 30 June 2023 Previous period: 30 June 2022

Results for announcement to the market

AUD
Revenues from ordinary activities
up
4.2%
to
1,354,535
down
13.6%
to
(3,448,860)
Loss for the period attributable to owners of
down
13.6%
to
(3,448,860)
Vectus Biosystems Limited
Loss from ordinary activities
after tax attributable to
Dividends (distributions)
Final dividend
Previous corresponding period
Amountper security Nil ¢
Franked amount per
security
Nil ¢
Nil ¢
Nil ¢

Brief explanation of the above

The Group has incurred an operating loss of $3,448,860 for the year ended 30 June 2023 (2022: Operating loss of $3,993,775) and the net equity has improved from a deficit of $3,533,995 as at 30 June 2022 to a surplus of $3,523,504 as at 30 June 2023. The operating cash burn rate for the year ended 30 June 2023 was $2,352,742 (2022: $4,441,231). The cash balance as at 30 June 2023 was $2,950,956.

This Appendix 4E should be read in conjunction with the Half Year Financial Report of the Group as at 31 December 2022. It is also recommended that the Appendix 4E be considered together with any public announcements made by the Group since commencement of the 2022-23 financial year in accordance with the continuous disclosure obligations arising under the Corporations Act 2001.

NTA backing 30-Jun-23 30-Jun-22
cents cents
Net tangible asset backing per ordinary share 6.62 (5.96)

Events occurring after Balance Date

No matter or circumstance has arisen since 30 June 2023 that has significantly affected or may significantly affect the consolidated entities' operations, the results of these operations, or the consolidated entities' state of affairs in future financial years.

Details of entities over which control has been gained or lost during the period

Not Applicable

Foreign Entities details

Not Applicable

Dividends

No dividends were paid or proposed during the financial year.

Audit or Review details

This report is based on accounts which have been audited.

Sign here: Date: 30 August 2023 ( ~~Director/C~~ ompany Secretary)

Appendix 4E Page 1

30/08/2023